Skip to main content
Paul Nghiem, MD, Dermatology, Seattle, WA, Fred Hutchinson Cancer Center

PaulTuan-XuanNghiemMDPhD

Dermatology Seattle, WA

George F. Odland Professor and Head, University of Washington Dermatology, Skin Oncology at Seattle Cancer Care Alliance, University of WA, Fred Hutchinson Cancer Research Center

Dr. Nghiem is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nghiem's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1995 - 1998
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1995
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1994
  • Stanford University
    Stanford UniversityPh.D., Program in Cancer Biology, 1994
  • Harvard University
    Harvard UniversityA.B., Biological Sciences, 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CA State Medical License
    CA State Medical License 2022 - 2024
  • WA State Medical License
    WA State Medical License 2005 - 2024
  • MA State Medical License
    MA State Medical License 1998 - 2006
  • American Board of Dermatology Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • (P33) Case Report: Neutron Radiation Therapy for Refractory Merkel Cell Carcinoma in an Immunotherapy Primed Patient Potentiates the Immune Response  
    Schaub SK, Stewart RD, Sandison GA, Arbuckle T, Liao JJ, Laramore GE, Zeng J, Rengan R, Tseng YD, Mayr NA, Bhatia S, Nghiem P, Parvathaneni U, International Journal of Radiation Oncology, Biology, Physics, 1/1/2018
  • Case Report: Neutron Radiation Therapy for Refractory Merkel Cell Carcinoma in an Immunotherapy Primed Patient Potentiates the Immune Response  
    Schaub SK, Stewart RD, Sandison GA, Arbuckle T, Liao JJ, Laramore GE, Zeng J, Rengan R, Tseng YD, Mayr NA, Bhatia S, Nghiem P, Parvathaneni U, International Journal of Radiation Oncology, Biology, Physics, 1/1/2018
  • Response  
    Bhatia S, Storer BE, Nghiem P, J Natl Cancer Inst, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet.
    Lu YP, Lou YR, Bernard JJ, Peng QY, Li T, Lin Y, Shih WJ, Nghiem P, Shapses S, Wagner GC, Conney AH, Proc Natl Acad Sci U S A, 1/1/2012
  • Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (Hsp70) modulators.
    Huryn D, Brodsky J, Brummond K, Chambers P, Eyre B, Ireland A, Kawasumi M, LaPorte M, Lloyd K, Manteau B, Nghiem P, Quade B, Wipf P, Proc Natl Acad Sci USA, 1/1/2011
  • Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase.
    Kawasumi M, Lemos B, Bradner JE, Thibodeau R, Kim YS, Schmidt M, Higgins E, Koo SW, Angle-Zahn A, Chen A, Levine D, Nguyen L, Heffernan TP, Longo I, Mandinova A, Lu YP..., Proc Natl Acad Sci USA, 1/1/2011
  • Join now to see all

Lectures

  • Late-breaking Research: Basic Science/Cutaneous Oncology/Pathology 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
  • Seattle Investigative Dermatology, MCC & the immunogenic principles transforming the care of all UV-induced skin cancers. 
    Oregon Convention Center, Portland, OR - 1/29/2017
  • MCC & the immunogenic principles transforming the care of all UV-induced skin cancers, Clinical scholars program session II: Emerging immunotherapies 
    Oregon Convention Center, Portland, OR - 1/29/2017
  • Join now to see all

Other

  • Cancer: The Final Frontier. 
    Nghiem P, Atlantic Monthly
    1/25/2016
  • "Cancer: The Final Frontier." 
    Nghiem P, The Atlantic Monthly
    1/25/2016
  • Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma. (Interview) 
    Nghiem P, AACR, ecancer.tv
    1/19/2016
  • Join now to see all

Press Mentions

  • Leadership Succession: Sunrise, Sunset
    Leadership Succession: Sunrise, SunsetMay 17th, 2023
  • Another Win for a JAK Inhibitor in Alopecia Areata
    Another Win for a JAK Inhibitor in Alopecia AreataMarch 19th, 2023
  • Rare Skin Cancer Patients Face 40 Pc Recurrence Rate: Study
    Rare Skin Cancer Patients Face 40 Pc Recurrence Rate: StudyApril 30th, 2022
  • Join now to see all

Grant Support

  • The Replication Checkpoint And Genomic Fidelity In SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2012
  • Humoral And Cellular Immunity In Polyomavirus-Linked Merkel Cell CarcinomaNational Cancer Institute2011
  • Pathogenetic And Prognostic Studies For Improved Therapy Of Merkel Cell CarcinomaNational Cancer Institute2009–2011
  • Targeting Mcpyv To Overcome Immune Evasion In Merkel Cell CarcinomaNational Cancer Institute2009–2010
  • The Replication Checkpoint And Genomic Fidelity In SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2008
  • The Replication Checkpoint And Genomic Fidelity In SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2005
  • The Replication Checkpoint And Genomic Fidelity In SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
  • Replication Checkpoint And Genomic Fidelity In SkinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003
  • Pik Related Kinases In The Response To DNA Damage By UVNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2003
  • Pik Related Kinases In The Response To DNA Damage By UVNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
  • Pik Related Kinases In The Response To DNA Damage By UVNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998

Professional Memberships

Hospital Affiliations